Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Learn why balancing short and long term goals leads to steadier progress and fewer stressful financial decisions.
28,657 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Geopolitical tensions push fuel costs higher, prompting DoorDash to fund more than $50 million in gas-price relief fo...
As AI workloads expand, data center power stocks are seeing a fresh wave of orders and upgraded guidance. This report...
Crystal Intelligence unveils Crystal AI Analytics, embedding an AI analyst in Crystal Expert to turn on-chain transfe...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
Geopolitical turmoil and potential chokepoint disruptions raise the odds of a renewed oil shock. Markets bracing $100...
A new wave of institutional capital is driving Ethereum’s next leg higher, with BlackRock and JPMorgan expanding on-c...
New labor data reveals a troubling disconnect: participation falls while unemployment headlines stay resilient. Inves...
Arizona lawmakers move two bills designed to curb local HOA and contractor licensing mandates, aiming to lower costs ...
Apollo Global Management has won the bidding for EasyJet, valuing the airline at about £5.7 billion ($7.7 billion) an...
As firms accelerate AI use, the hidden cost your rollout is exposing becomes clearer: burnout among the very employee...
A tidal wave of data centers is pushing power demands higher. Five dividend stocks are quietly funding the grid expan...